Berberine affects osteosarcoma via downregulating the caspase-1/IL-1β signaling axis

Jin,Hao; Jin,Xin; Cao,Boran; Wang,Wenbo

doi:10.3892/or.2016.5327

Berberine affects osteosarcoma via downregulating the caspase-1/IL-1β signaling axis

Authors:
- Hao Jin
- Xin Jin
- Boran Cao
- Wenbo Wang
View Affiliations

Affiliations: Department of Orthopaedics, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China
Published online on: December 16, 2016 https://doi.org/10.3892/or.2016.5327
Pages: 729-736
Copyright: © Jin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Osteosarcoma is one of the most devastating cancers with associated poor prognosis. Chronic bone inflammation frequently predisposes to tumorigenesis and progression of osteosarcoma. In the tumor inflammatory microenvironment, caspase-1 and its processed cytokines such as interleukin 1β (IL-1β) play an important role in the occurrence and development of cancer. Berberine is an isoquinoline alkaloid extracted from the dry root of Coptidis Rhizoma, which has been found to exhibit significant anticancer effects on a wide spectrum of carcinomas including osteosarcoma. However, the mechanisms underlying the anticancer effects of berberine in osteosarcoma remain poorly understood and their elucidation is critical for developing improved therapies. In the present study, we investigated the potential mechanism underlying the anticancer effect of berberine in osteosarcoma. We found that the expression of caspase-1 and its downstream target IL-1β were higher in osteosarcoma cells compared with normal cells both in vitro and in vivo. Furthermore, administration of berberine is capable of reducing the expression of caspase-1 and IL-1β in osteosarcoma cells and inhibiting the growth of tumor cells. Based on the above, for the first time, we propose the hyposis that berberine could gengerate an anti-osteosarcoma property through downregulating caspase-1/IL-1β inflammatory signaling axis.

View Figures

View References

1	Sampson VB, Kamara DF and Kolb EA: Xenograft and genetically engineered mouse model systems of osteosarcoma and Ewings sarcoma: Tumor models for cancer drug discovery. Expert Opin Drug Discov. 8:1181–1189. 2013. View Article : Google Scholar : PubMed/NCBI
2	Tabatabaei SH, Jahanshahi G and Marvasti F Dehghan: Diagnostic challenges of low-grade central osteosarcoma of jaw: A literature review. J Dent (Shiraz). 16:62–67. 2015.PubMed/NCBI
3	Li S, Sun W, Wang H, Zuo D, Hua Y and Cai Z: Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal. Tumour Biol. 36:1329–1338. 2015. View Article : Google Scholar : PubMed/NCBI
4	Wang Y and Teng JS: Increased multi-drug resistance and reduced apoptosis in osteosarcoma side population cells are crucial factors for tumor recurrence. Exp Ther Med. 12:81–86. 2016.PubMed/NCBI
5	Dmitrieva OS, Shilovskiy IP, Khaitov MR and Grivennikov SI: Interleukins 1 and 6 as main mediators of inflammation and cancer. Biochemistry. 81:80–90. 2016.PubMed/NCBI
6	Karin M and Greten FR: NF-kappaB: Linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 5:749–759. 2005. View Article : Google Scholar : PubMed/NCBI
7	Chen XW and Zhou SF: Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis. Drug Des Devel Ther. 9:2941–2946. 2015.PubMed/NCBI
8	Jearaphunt M, Noonin C, Jiravanichpaisal P, Nakamura S, Tassanakajon A, Söderhäll I and Söderhäll K: Caspase-1-like regulation of the proPO-system and role of ppA and caspase-1-like cleaved peptides from proPO in innate immunity. PLoS Pathog. 10:e10040592014. View Article : Google Scholar : PubMed/NCBI
9	Ataide MA, Andrade WA, Zamboni DS, Wang D, Souza MC, Franklin BS, Elian S, Martins FS, Pereira D, Reed G, et al: Malaria-induced NLRP12/NLRP3-dependent caspase-1 activation mediates inflammation and hypersensitivity to bacterial superinfection. PLoS Pathog. 10:e10038852014. View Article : Google Scholar : PubMed/NCBI
10	Exline MC, Justiniano S, Hollyfield JL, Berhe F, Besecker BY, Das S, Wewers MD and Sarkar A: Microvesicular caspase-1 mediates lymphocyte apoptosis in sepsis. PLoS One. 9:e909682014. View Article : Google Scholar : PubMed/NCBI
11	Miao EA, Rajan JV and Aderem A: Caspase-1-induced pyroptotic cell death. Immunol Rev. 243:206–214. 2011. View Article : Google Scholar : PubMed/NCBI
12	Yu D, Fu S, Cao Z, Bao M, Zhang G, Pan Y, Liu W and Zhou Q: Unraveling the novel anti-osteosarcoma function of coptisine and its mechanisms. Toxicol Lett. 226:328–336. 2014. View Article : Google Scholar : PubMed/NCBI
13	Su K, Hu P, Wang X, Kuang C, Xiang Q, Yang F, Xiang J, Zhu S, Wei L and Zhang J: Tumor suppressor berberine binds VASP to inhibit cell migration in basal-like breast cancer. Oncotarget. Jun 13–2016.doi: 10.18632/oncotarget.9968.
14	Zhang XZ, Wang L, Liu DW, Tang GY and Zhang HY: Synergistic inhibitory effect of berberine and d-limonene on human gastric carcinoma cell line MGC803. J Med Food. 17:955–962. 2014. View Article : Google Scholar : PubMed/NCBI
15	Jin X, Yan TH, Yan L, Li Q, Wang RL, Hu ZL, Jiang YY, Sun QY and Cao YB: Design, synthesis, and anticancer activity of novel berberine derivatives prepared via CuAAC ‘click’ chemistry as potential anticancer agents. Drug Des Devel Ther. 8:1047–1059. 2014. View Article : Google Scholar : PubMed/NCBI
16	Zhu Y, Ma N, Li HX, Tian L, Ba YF and Hao B: Berberine induces apoptosis and DNA damage in MG-63 human osteosarcoma cells. Mol Med Rep. 10:1734–1738. 2014.PubMed/NCBI
17	Liu Z, Liu Q, Xu B, Wu J, Guo C, Zhu F, Yang Q, Gao G, Gong Y and Shao C: Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage. Mutat Res. 662:75–83. 2009. View Article : Google Scholar : PubMed/NCBI
18	Man SM and Kanneganti TD: Converging roles of caspases in inflammasome activation, cell death and innate immunity. Nat Rev Immunol. 16:7–21. 2016. View Article : Google Scholar : PubMed/NCBI
19	Jin Y, Wu W, Zhang W, Zhao Y, Wu Y, Ge G, Ba Y, Guo Q, Gao T, Chi X, et al: Involvement of EGF receptor signaling and NLRP12 inflammasome in fine particulate matter-induced lung inflammation in mice. Environ Toxicol. Jul 5–2016.(Epub ahead of print) doi.org/10.1002/tox.22308. View Article : Google Scholar
20	Heymann D, Ory B, Blanchard F, Heymann MF, Coipeau P, Charrier C, Couillaud S, Thiery JP, Gouin F and Redini F: Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma. Bone. 37:74–86. 2005. View Article : Google Scholar : PubMed/NCBI
21	Sansone P and Bromberg J: Environment, inflammation, and cancer. Curr Opin Genet Dev. 21:80–85. 2011. View Article : Google Scholar : PubMed/NCBI
22	Coussens LM and Werb Z: Inflammation and cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
23	Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008. View Article : Google Scholar : PubMed/NCBI
24	Vakkila J and Lotze MT: Inflammation and necrosis promote tumour growth. Nat Rev Immunol. 4:641–648. 2004. View Article : Google Scholar : PubMed/NCBI
25	Persidsky Y, Hill J, Zhang M, Dykstra H, Winfield M, Reichenbach NL, Potula R, Mukherjee A, Ramirez SH and Rom S: Dysfunction of brain pericytes in chronic neuroinflammation. J Cereb Blood Flow Metab. 36:794–807. 2016. View Article : Google Scholar : PubMed/NCBI
26	Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Van Ness K, Greenstreet TA, March CJ, Kronheim SR, Druck T, Cannizzaro LA, et al: Molecular cloning of the interleukin-1 beta converting enzyme. Science. 256:97–100. 1992. View Article : Google Scholar : PubMed/NCBI
27	Mariathasan S, Newton K, Monack DM, Vucic D, French DM, Lee WP, Roose-Girma M, Erickson S and Dixit VM: Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature. 430:213–218. 2004. View Article : Google Scholar : PubMed/NCBI
28	Scott EN, Gescher AJ, Steward WP and Brown K: Development of dietary phytochemical chemopreventive agents: Biomarkers and choice of dose for early clinical trials. Cancer Prev Res (Phila). 2:525–530. 2009. View Article : Google Scholar : PubMed/NCBI
29	Mantena SK, Sharma SD and Katiyar SK: Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP. Carcinogenesis. 27:2018–2027. 2006. View Article : Google Scholar : PubMed/NCBI
30	Katiyar SK, Meeran SM, Katiyar N and Akhtar S: p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Mol Carcinog. 48:24–37. 2009. View Article : Google Scholar : PubMed/NCBI
31	Letasiová S, Jantová S, Miko M, Ovádeková R and Horváthová M: Effect of berberine on proliferation, biosynthesis of macromolecules, cell cycle and induction of intercalation with DNA, dsDNA damage and apoptosis in Ehrlich ascites carcinoma cells. J Pharm Pharmacol. 58:263–270. 2006. View Article : Google Scholar : PubMed/NCBI
32	Xu H, Zhao X, Liu X, Xu P, Zhang K and Lin X: Antitumor effects of traditional Chinese medicine targeting the cellular apoptotic pathway. Drug Des Devel Ther. 9:2735–2744. 2015.PubMed/NCBI